Synthetic data only. Never enter patient information; nothing is sent or stored. For clinicians. Not FDA cleared.

CPE-011 · synthetic case ANEM-FX-03

Macrocytic anemia with low B12 and hypersegmented neutrophils

MCV 112.

Synthetic · no real patientAuthored by Biod · reviewed by Dr. AmaralAnemia engine v1.0.0

Purpose: MCV 112.

Inputs the engine received

CBC and reticulocytes

Hemoglobin
9.2 g/dL
Hematocrit
28 %
MCV
112 fL
Reticulocytes
0.6 %

Patient

Age
65 years
Sex
Male

Iron, vitamins and inflammation

Vitamin B12
140 pg/mL

Blood film and other context

Hypersegmented neutrophils
Yes

What the engine reports

Detected clinical pattern

Macrocytic Anemia — Pattern Compatible With B12 or Folate Deficiency

Moderate anemia, macrocytic. A pattern for physician review; the cause still has to be found.

  • Severity: Moderate anemia (Hb 9.2 g/dL)
  • Morphology: Macrocytic (MCV >100)
  • Marrow response: Marrow response inadequate (RPI 0.19)

Calculations

Corrected reticulocyte count
0.37%

Reticulocyte % × (hematocrit ÷ 45).

Reticulocyte production index
0.19

Corrected count ÷ maturation factor. 2 or more is an appropriate marrow response.

Recommended next steps

For physician consideration. Urgent review always comes first.

  1. 1Check B12 before folic acid; the Vitamin B12 and Folate Pattern Engine applies the safety rules.

Missing information

  • Ferritin (and transferrin saturation).
Evidence and rule trace · 6 rules

AN-CALC-01Derived values

Inputs: RPI 0.19

Derived values calculated.

AN-01Anemia present, with severity

Inputs: hemoglobin 9.2 g/dL (<13)

Anemia, moderate.

AN-02Morphology by MCV

Inputs: MCV 112 fL

Macrocytic anemia.

AN-03Marrow response

Inputs: retic 0.6% · hematocrit 28% · RPI 0.19

Inadequate marrow response.

AN-13Megaloblastic pattern

Inputs: MCV 112 fL · B12 140 pg/mL · hypersegmented neutrophils

Pattern compatible with vitamin B12 or folate deficiency.

AN-MISS-01Information needed

Inputs: Ferritin

First-line studies are incomplete.

Evidence

  • EV-WHO-HB-2011 · World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva: WHO; 2011.
  • EV-TEFFERI-2003 · Tefferi A. Anemia in adults: a contemporary approach to diagnosis. Mayo Clin Proc. 2003;78(10):1274-1280.
  • EV-MENTZER-1973 · Mentzer WC Jr. Differentiation of iron deficiency from thalassaemia trait. Lancet. 1973;1(7808):882.
  • EV-DEVALIA-2014 · Devalia V, Hamilton MS, Molloy AM; British Committee for Standards in Haematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166(4):496-513.

Physician adjudication required. Clinical decision support for physician review. This output classifies anemia by morphology and marrow response and lists patterns and safety considerations. It does not diagnose a cause, rank causes by probability, or select treatment or transfusion. Physician adjudication is required.

Change the values

The same engine, starting from this case. Change any value and watch the pattern and the rule trace react.

Morphology

  1. ✓ Microcytic

    MCV <80 fL

  2. ✓ Normocytic

    MCV 80–100 fL

  3. ● Macrocytic

    MCV >100 fL

Marrow response (reticulocyte production index)

  1. ● Inadequate · RPI <2

    Hypoproliferative: deficiency, inflammation, kidney, marrow

  2. ○ Appropriate · RPI ≥2

    Blood loss, hemolysis or recovery

CBC and reticulocytes
  • <7
  • 7–8
  • 8–11
  • 11–13
  • ≥13
Patient
Sex
Iron, vitamins and inflammation
Hemolysis, kidney and thyroid

250 U/L is assumed when empty.

Blood film and other context

Live result · computed in your browser

Detected clinical pattern

Macrocytic Anemia — Pattern Compatible With B12 or Folate Deficiency

Moderate anemia, macrocytic. A pattern for physician review; the cause still has to be found.

  • Severity: Moderate anemia (Hb 9.2 g/dL)
  • Morphology: Macrocytic (MCV >100)
  • Marrow response: Marrow response inadequate (RPI 0.19)

Calculations

Corrected reticulocyte count
0.37%

Reticulocyte % × (hematocrit ÷ 45).

Reticulocyte production index
0.19

Corrected count ÷ maturation factor. 2 or more is an appropriate marrow response.

Recommended next steps

For physician consideration. Urgent review always comes first.

  1. 1Check B12 before folic acid; the Vitamin B12 and Folate Pattern Engine applies the safety rules.

Missing information

  • Ferritin (and transferrin saturation).
Evidence and rule trace · 6 rules

AN-CALC-01Derived values

Inputs: RPI 0.19

Derived values calculated.

AN-01Anemia present, with severity

Inputs: hemoglobin 9.2 g/dL (<13)

Anemia, moderate.

AN-02Morphology by MCV

Inputs: MCV 112 fL

Macrocytic anemia.

AN-03Marrow response

Inputs: retic 0.6% · hematocrit 28% · RPI 0.19

Inadequate marrow response.

AN-13Megaloblastic pattern

Inputs: MCV 112 fL · B12 140 pg/mL · hypersegmented neutrophils

Pattern compatible with vitamin B12 or folate deficiency.

AN-MISS-01Information needed

Inputs: Ferritin

First-line studies are incomplete.

Evidence

  • EV-WHO-HB-2011 · World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Geneva: WHO; 2011.
  • EV-TEFFERI-2003 · Tefferi A. Anemia in adults: a contemporary approach to diagnosis. Mayo Clin Proc. 2003;78(10):1274-1280.
  • EV-MENTZER-1973 · Mentzer WC Jr. Differentiation of iron deficiency from thalassaemia trait. Lancet. 1973;1(7808):882.
  • EV-DEVALIA-2014 · Devalia V, Hamilton MS, Molloy AM; British Committee for Standards in Haematology. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol. 2014;166(4):496-513.

Physician adjudication required. Clinical decision support for physician review. This output classifies anemia by morphology and marrow response and lists patterns and safety considerations. It does not diagnose a cause, rank causes by probability, or select treatment or transfusion. Physician adjudication is required.

More anemia cases

All anemia cases

The Clinical Intelligence Layer — transforming fragmented clinical information into structured intelligence for clinician review and action.

Contact Biod